维普期刊资源整合服务平台（V6.5）

31篇 您的检索式：作者名="MOLIMARD M"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Analysis of allergen immunotherapy studies shows increased clinical efficacy in highly symptomatic subjects显示文摘	HOWARTH P MALLING H MOLIMARD M	2012	Allergy2012，67，：	1
2	Beneficial effects of probiotics in upper respiratory tract infections and their mechanical actions to antagonize pathogens 显示文摘	Popova M Molimard P Courau S	2012	J Appl Microbiol2012，113，6：	1
3	Gender and interindividual vari- ability in pharmacokinetics显示文摘	Nicolas JM Espie P Molimard M	2009	Drug Metab Rev2009，41，3：	1
4	Approach to bronchial hyperreactivity in vitro显示文摘	Molimard M Advenier C	1999	Therapie1999，54，1：	1
5	Interleukin-1β-induced hyperresponsiveness to substance P in isolated human bronchi 显示文摘	Barchasz E Naline E Molimard M	1999	Eur J Parmacol1999，379，：	1
6	Prevalence and associated factors of oropharyngeal side effects in users of inhaled corticosteroids in a real- life setting 显示文摘	Molimard M Le G V Robinson P	2010	J Aerosol Med Pulm Drug Deliv2010，23，2：	1
7	The scientific rationale for combining long acting beta2-agonists and muscarinic antagonists in COPD显示文摘	Cazzola M Molimard M	2010	Pulm Pharmacol Ther2010，23，4：	1
8	Pharmacokinetics and pharmacodynamics of nilotinib in gastrointestinal stromal tumors 显示文摘	Trent J Molimard M	2011	Semin Oncol2011，381，：	1
9	Comparison of pharmacokinetics and metabolism of desloratadine, fexofenadine, levocetirizine and mizolastine in humans显示文摘	Molimard M Diquet B Benedetti MS	2004	Fundam Clin Pharmacol2004，18，4：	1
10	Omalizumab reduces oral corticosteroid use in patients with severe allergic asthma: real-life data显示文摘	Molimard M Buhl R Niven R	2010	Respir Med2010，104，9：	1
11	Prevalence and associated fac- tors of oropharyngeal side effects in users of inhaled eortieosteroids in a re- al - life setting 显示文摘	Molimard M Le Gros V Robinson P	2010	J Aerosol Med Pulm Drug Deliv2010，23，2：	1
12	Prevalence and associated fac- tors of oropharyngeal side effects in users of inhaled eorticosteroids in a re- al - life setting显示文摘	Molimard M Le Gnus V Robinson P	2010	J Aerosol Med Pulm Drug Deliv2010，23，2：	1
13	Mast cell tryptase as a mediator of hyperresponsiveness in human isolated bronchi显示文摘	Berger P Compton SJ Molimard M	1999	Ciin Exp Allergy1999，29，：	1
14	Prevalence and associated factors of oropharyngeal side effects in users of inhaled corticosteroids in a real-life settin显示文摘	Molimard M Le Gros V Robinson P	2010	J Aerosol Med Pulm Drug Deliv2010，23，2：	1
15	Comparison of A60 and three glycolipid antigens in an ELISA test for tuberculosis显示文摘	Simonney N Molina JM Molimard M	1996	Clin Microbiol Infect1996，2，3：	1
16	In vitro-induced human airway hyperresponsiveness to bradykinin 显示文摘	MOLIMARD M NALINE E BOICHOT E	1998	Eur Respir J1998，12，6：	1
17	Analysis of allergen Immunotherapy studies shows increased clinical efficacy in highly symptomatic patients显示文摘	Howarth P Malling H J Molimard M P	2012	Allergy2012，67，3：	1
18	Mast cell tryptase as a mediator of hyperresponsiveness in human isolated bronchi 显示文摘	Berger P Compton SJ Molimard M	1999	elin Exp Aller-gy1999，29，6：	1
19	Prevalence and associated factors of oropharyngeal side effects in users of inhaled corticosteroids in a real-life setting显示文摘	Molimard M Le Gros V Robinson P	2010	J Aerosol Med Pulm Drug Deliv2010，23，2：	1
20	Prevalence and associated factors of oropharyngeal side effects in users of inhaled corticostemids in a real -life setting 显示文摘	Molimard M Le Gros V Robinson P	2010	J Aerosol Med Pulm Drug Deliv2010，23，2：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示